Product Information
DAPSONE 25 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.5448 per EA under NDC 64980056703. Its NADAC has been published 133 times since Dec 13, 2023.
Strength
25 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980056703
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DAPSONEApproval Type
Generic (ANDA)
FDA Application
ANDA207165On Market Since
7/20/2023
Pharmacological Classes
Price Statistics
The NADAC for DAPSONE 25 MG TABLET has been published 133 times since Dec 13, 2023, and over the history we have for it it has declined 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5448 per EA |
|---|---|
| All-time high | $0.7014 (Oct 16, 2024) |
| All-time low | $0.3414 (Jul 17, 2024) |
| 52-week high | $0.5908 |
| 52-week low | $0.5113 |
| Median price | $0.5606 |
| Average price | $0.5547 |
| Largest weekly change | +56.5% (Aug 21, 2024) |
| Weeks tracked | 133 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DAPSONE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DAPSONE 25 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.5448 per EA (NDC 64980056703), effective Jun 24, 2026.
How has the price of DAPSONE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for DAPSONE 25 MG TABLET has declined 4.8%. It has been tracked across 133 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for DAPSONE 25 MG TABLET?
Since Dec 13, 2023, the NADAC for DAPSONE 25 MG TABLET has ranged from a low of $0.3414 (Jul 17, 2024) to a high of $0.7014 (Oct 16, 2024), with a median of $0.5606 per EA.
Are there cheaper alternatives to DAPSONE 25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DAPSONE 25 MG TABLET, but none are currently priced below it.
Who manufactures DAPSONE 25 MG TABLET?
DAPSONE 25 MG TABLET (NDC 64980056703) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification